Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Lonberg

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|September 10, 2005
Human antibodies from transgenic animalsNils Lonberg
Current Opinion in Immunology|July 9, 2008
Fully human antibodies from transgenic mouse and phage display platformsNils Lonberg
Cancer Immunology Research|February 25, 2025
The Problem with Syngeneic Mouse Tumor ModelsNils Lonberg
Cancer Immunology Research|April 5, 2017
Masterful Antibodies: Checkpoint BlockadeNils Lonberg, Alan J Korman
Nature Reviews. Drug Discovery|December 23, 2021
The foundations of immune checkpoint blockade and the ipilimumab approval decennialAlan J Korman, Sarah C Garrett-Thomson, Nils Lonberg
Pharmacology & Therapeutics|December 6, 2014
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: the Bristol-Myers Squibb experienceDavid Berman, Alan Korman, Ronald Peck, et al.
Cell Systems|October 8, 2020
Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza VirusAssaf Amitai, Maya Sangesland, Ralston M Barnes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaquesTibor Keler, Ed Halk, Laura Vitale, et al.
Cloning and Stem Cells|May 15, 2002
Production of human monoclonal and polyclonal antibodies in TransChromo animalsIsao Ishida, Kazuma Tomizuka, Hitoshi Yoshida, et al.
Frontiers in Immunology|September 27, 2021
Engineering an Antibody V Gene-Selective VaccineLarance Ronsard, Ashraf S Yousif, Julianne Peabody, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|September 10, 2005
Human antibodies from transgenic animalsNils Lonberg
Current Opinion in Immunology|July 9, 2008
Fully human antibodies from transgenic mouse and phage display platformsNils Lonberg
Cancer Immunology Research|February 25, 2025
The Problem with Syngeneic Mouse Tumor ModelsNils Lonberg
Cancer Immunology Research|April 5, 2017
Masterful Antibodies: Checkpoint BlockadeNils Lonberg, Alan J Korman
Nature Reviews. Drug Discovery|December 23, 2021
The foundations of immune checkpoint blockade and the ipilimumab approval decennialAlan J Korman, Sarah C Garrett-Thomson, Nils Lonberg
Pharmacology & Therapeutics|December 6, 2014
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: the Bristol-Myers Squibb experienceDavid Berman, Alan Korman, Ronald Peck, et al.
Cell Systems|October 8, 2020
Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza VirusAssaf Amitai, Maya Sangesland, Ralston M Barnes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaquesTibor Keler, Ed Halk, Laura Vitale, et al.
Cloning and Stem Cells|May 15, 2002
Production of human monoclonal and polyclonal antibodies in TransChromo animalsIsao Ishida, Kazuma Tomizuka, Hitoshi Yoshida, et al.
Frontiers in Immunology|September 27, 2021
Engineering an Antibody V Gene-Selective VaccineLarance Ronsard, Ashraf S Yousif, Julianne Peabody, et al.
Pageof 2